Aspen Pharmacare Holdings Limited: Dealing In Aspen Securities

In compliance with the JSE Limited Listings Requirements, shareholders are advised of the following dealings in Aspen’s securities by a third-party intermediary (“the Intermediary”).
A hedging transaction was entered into with the Intermediary to enable the Company to settle its future obligation to employees participating in the SA Management Deferred Incentive Bonus Scheme (“the Scheme”) of Aspen and three of its wholly owned South African subsidiaries, namely Pharmacare Limited, Aspen Finance (Pty) Limited and Fine Chemicals Corporation (Pty) Ltd. In terms of this hedging transaction the Intermediary acquired Aspen shares as follows:
Date of transaction: 26 November 2024
Nature and details of the transaction On-market purchase of securities to satisfy the future
By intermediary: Obligations towards participants of the Scheme
Number of securities: 367 662
Purchase price: R169.00
The total value of the transaction: R62 134 878
Class of securities: Ordinary Shares
Nature of interest: Direct beneficial
Clearance obtained: Yes
For the full document click the link below:
Aspen Pharmacare Holdings Limited
Stay ahead of the curve! Subscribe to InsidEntity for daily updates on all your favourite companies.